Buy IBRX by Apr 15, 2026.

· Published Jan 15, 2026 13:37 · Valid until Apr 15, 2026 · FAILURE

🚀 ImmunityBio Reports Continued Execution and Sales Momentum With $113 Million of Preliminary Net Product Revenue—a 700% increase year-over-year

— ORIGINAL POST · 🚀 ImmunityBio Reports Continued Execution and Sales Momentum With $113 Million of Preliminary Net Product Revenue—a 700% increase year-over-year · r/Shortsqueeze · Jan 15, 2026

-0.36

of possible +1.00 · Closed at expiry

Direction ✗

Magnitude -3.6%

Conviction Med

View profile →

Followers 1

Created Jul 22

Asset IBRX →